Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Trinity Biotech, Plc — Predicate Candidate Screening
5 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
197 daysmedian FDA review time
219 days90th percentile
5clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K014233 | CAPTIAM SYPHILIS-G ASSAY | Trinity Biotech, Plc | 2002-01-24 | 29 | 0 |
| K011709 | UNI-GOLD STREP A TEST KIT | Trinity Biotech, Plc | 2001-11-08 | 157 | 0 |
| K001525 | CAPTIA SYPHILIS-G ELISA TEST SYSTEM | Trinity Biotech, Plc | 2000-11-29 | 197 | 0 |
| K991697 | UNI-GOLD H. PYLORI | Trinity Biotech, Plc | 1999-12-21 | 217 | 0 |
| K982373 | UNI-GOLD STREP A TEST KIT | Trinity Biotech, Plc | 1999-02-11 | 219 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda